← Back
$NEUP All transactions

Neuphoria Therapeutics Inc.

A

$ Value

$139K

Shares

27,000

Price

$5

Filed

May 19

Insider

Name

Papapetropoulos Spyros

Title

President and CEO

CIK

0001832694

Roles

Director Officer

Transaction Details

Transaction Date

2025-04-16

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

39,529

Footnotes

The original Form 4, filed on April 17, 2025, is amended by this Form 4/A solely to correct a clerical error, which resulted in misreporting the number of derivative securities acquired (Item 5) and amount of securities underlying the derivative securities (Item 7) as 270,000 when the actual number of derivative securities acquired and amount of securities underlying the derivative securities was 27,000. With the correction of the clerical error, the number of derivative securities beneficially owned following the reported transaction (Item 9) is 39,529 shares. | Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a three-year period at the rate of 2.78% of the shares of Common Stock on the last day of each month following September 1, 2024 until the options are vested.

Filing Info

Accession No.

0001213900-25-045445

Form Type

4/A

Issuer CIK

0001191070

Papapetropoulos Spyros's History

Date Ticker Type Value
2025-08-27 NEUP A $286K
2025-06-04 LPCN A $6K
2025-04-16 NEUP A $139K

Other Insiders at NEUP (90d)

No other insider activity at this issuer in the last 90 days.